P I Industries
P I Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #19 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
FY27 revenue growth guidance expected to be in the lower single-digit range, subject to industry cycle and conditions. PI Industries expects a positive growth trajectory for FY27, with revenue growth in the lower single digits, contingent on industry cycles and conditions.
From P I Industries's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- FY27 revenue growth guidance expected to be in the lower single-digit range, subject to industry cycle and conditions.
- Positive growth trajectory anticipated, especially recovery in exports in the second half of FY27 supported by new product launches.
- Domestic market volume growth of 12% in Q1 FY27, translating to 3% revenue growth; outlook improving with better monsoon conditions.
- Biologicals showing aggressive growth of 50% with a 3-year CAGR of 15%, with expansion in global markets like Brazil, Mexico, Europe, and the US.
- New product launches planned across Agchem, Electronics, and Pharma segments, with 4-5 new molecules expected in FY27.
- New generation and innovative products targeted for at least three-digit million-dollar revenue potential over medium to long term.
2 more points from P I Industries's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what P I Industries said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY27 capex guidance is Rs. 700 to Rs. 800 crore, maintaining steady investment momentum.
- Current capex (~Rs. 250 crore in Q1) allocated across:
- Existing manufacturing asset enhancements
- New verticals development
- Innovation-led approaches in geographies and products
- Investment focused on building sustainable, advanced capabilities in Agchem, Pharma, and Electronic/Specialty chemicals.
- Emphasis on commissioning world’s largest flow chemistry plants enabling sustainable, safer, and cost-efficient production.
- Strategic investments made to support global biologicals platform scaling, including field trials and grower engagements.
2 more points from P I Industries's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what P I Industries said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The current order book is cited at approximately USD 1.2 billion, which is stable sequentially.
- The company expects continued order inflows, particularly in Pharma CRDMO, Biologicals, and Agchem segments.
- There are some sequential delays in pharma order book transitions, but the orders are largely securitized and expected to convert over time.
- The business is in early stages for pharma and biologicals with some volatility; as scale and portfolio expand, volatility will reduce.
2 more points from P I Industries's call on order book
Create a free account to keep reading this call
P I Industries — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.6K Cr, net profit ₹200 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What P I Industries Ltd's management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Fertilizers & Agrochemicals this season
- Rama Phosphates (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹22,480 Lacs, up 18% YoY from ₹19,031 Lacs in Q1 FY26. Key investor presentation takeaways from Rama Phosphates's Q1 FY27 inves
- Advance Agrolife (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
- Bhagiradha Chem. (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Sumitomo Chemi. (Q1 FY27)
1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
P I Industries and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were P I Industries Q1 FY27 results?
FY27 revenue growth guidance expected to be in the lower single-digit range, subject to industry cycle and conditions. PI Industries expects a positive growth trajectory for FY27, with revenue growth in the lower single digits, contingent on industry cycles and conditions.
What is P I Industries share price analysis?
P I Industries currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹37,881 Cr. Investors should review the full earnings analysis for detailed insights.
Is P I Industries planning capital expenditure?
FY27 capex guidance is Rs.
Keep P I Industries on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
